METTL3 and neoplasm: In summary, our findings unveil a signaling network involving METTL3/FGF2/PI3K/AKT/mTOR in LUAD and shed light on the molecular mechanism underlying tumor malignant progression while holding great significance for targeted therapy in research on LUAD.